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Hidradenitis suppurativa (HS) is a chronic inflamma-
tory skin disease defined by recurrent nodules, tunnels 
(sinus tracts) and scarring involving the intertriginous 
regions. The clinical course of HS is compatible with 
a biofilm-driven disease, and biofilm has been des-
cribed in lesional HS skin. We therefore hypothesized 
that clinically unaffected HS skin would also have an 
increased presence of biofilm compared with that of 
healthy controls. We conducted a case-control study, 
investigating the morphology of the axillary skin mi-
crobiota. Peptide nucleic acid – fluore scence in situ 
hybridization probes were used in combination with 
confocal laser scanning microscopy. Significant diffe-
rences were found in both distribution and quantity of 
the cutaneous microbiota in clinically non-affected ax-
illary skin of patients with HS compared with healthy 
controls. Surprisingly, we detected fewer bacteria and 
less biofilm in patients with HS. The reduced micro-
biota in patients with HS may play an important role in 
the early course of the disease.
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Hidradenitis suppurativa (HS) is a chronic inflam-matory skin disease defined by recurrent nodules, 
tunnels (sinus tracts) and scarring involving the intertri-
ginous regions. The nodules may expand progressively to 
abscesses and subsequently rupture, causing suppuration 
and malodorous discharge (1). The prevalence of HS has 
been estimated as 1–4% in European populations (2–4), 
while a mean incidence of 6 per 100,000 person per year 
has been found in an American study (5). Although the 
patho genesis of HS is unknown, the role of the cutaneous 
commensal bacterial community (microbiota) and its 
potential relationship to the innate immune system in HS 
appears to be of increasing interest (6–9). Several studies 
have hypothesized that a synergistic interaction between 
the commensal microbiota and aberrant innate immune 
responses could be a pivotal factor in the pathogenesis 
of HS (10–12). However, the structure of the bacterial 
population, as well as the diversity at strain level, is po-
orly investigated in patients with HS (13–17). Previous 
studies have furthermore been restricted to lesional skin 
without inclusion of healthy control groups, and micro-
biological investigations of clinically normal HS skin of 
the intertriginous regions are limited. 
The clinical course of HS is compatible with a biofilm-
driven disease. A biofilm is a microbial-derived, sessile 
community, characterized by cells attached to a substra-
tum, interface or to each other embedded in a matrix of 
extracellular polymeric substances (18). Bacterial biofilm 
infections are clinically intractable infections and noto-
riously a challenge to eradicate, as biofilm communities 
exhibit an altered phenotype with respect to growth rate 
and gene transcription, rendering the bacteria tolerant 
to antibiotic treatment and the host defence (19). In 
particular, in chronic wounds, biofilms are thought to 
delay wound healing and prolong inflammation (20–23). 
As recently stated in the European S1 guidelines, the 
early stage in the pathogenesis of HS is often referred 
to as an initially sterile process (24). HS is therefore not 
considered a traditionally infectious disease. However, 
in lesional skin, biofilm has previously been described 
and has therefore been suggested to play a role in HS 
(25, 26). In the 2 studies biofilms were by confocal laser 
scanning microscopy (CLSM) and fluorescence in situ 
hybridization (FISH) visualized in sinus tracts and in 
hair follicles of the lesions. Thus, the pathobiology of HS 
may elicit formations of bacterial aggregates (biofilms), 
in particular in anoxic cavities, such as sinus tracts or 
dilated hair follicles. 
If biofilm plays a role in the aetiology of HS, we 
hypothesized that clinically, unaffected HS skin also 
would have an increased presence of bacteria and biofilm 
compared with that of healthy controls. We therefore 
conducted a case-control study, investigating the axillary 
skin microbiota comparing patients with HS and healthy 
controls. Peptide nucleic acid (PNA)-FISH probes were 
used in combination with CLSM. PNA-FISH probes 
target specific bacterial ribosomal RNA sequences in the 
bacterial cells (25, 27). PNA diffuses through the bacte-
rial cell wall due to its uncharged backbone. Importantly, 
PNA-FISH offers high specificity due to the excellent 
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thermal stability of the RNA-PNA hybrid complexes. 
Compared with traditional light microscopy and con-
ventional staining methods (e.g. Gram-staining), PNA-
FISH in conjunction with CLSM offer high-resolution 
3-D images, as well as information about live and dead 
bacterial cells. Knowledge of the potential variations in 
the spatial distribution and quantity of the microbiota and 
biofilm in unaffected HS skin and healthy controls may 
offer novel insights into the early pathogenesis of HS. 
MATERIALS AND METHODS 
Ethical statement
This study was accepted by the ethics committee of Region 
Zealand (project number SJ-420) and the data protection agency 
(REG-105-2014) in Denmark. The study was conducted at Ros-
kilde Hospital, Department of Dermatology from October 2014 
to August 2015. Written informed consent was obtained from all 
study participants.
Study design
An exploratory case-control study comparing individuals with 
a diagnosis of HS vs. healthy controls (n = 24, respectively) was 
performed. 
Study participants
All cases were consecutive HS patients the from Department of 
Dermatology, Roskilde Hospital. Healthy controls were recruited 
at the University of Copenhagen and among the staff at the De-
partment of Dermatology, Roskilde Hospital.
Inclusion criteria. All cases had a verified diagnosis of HS (ICD-10 
code: L732) at the Department of Dermatology, Roskilde Hospital. 
All were aged over 18 years and non-pregnant. All HS patients 
reported intermittent activity of inflamed nodules in both axilla. 
Thus, all included patients had a history of previously active le-
sions at the investigated site. However, all biopsies contained only 
clinically normal-appearing skin (without scarring, inflammation 
or swelling) with clinically visible hair follicles. 
Inclusion criteria of healthy controls. No known skin disease. No 
visible skin disease in axillae, in particular no folliculitis, nodules, 
tunnels (sinus tracts), abscesses or scars compatible with current 
or previous HS lesions.
Exclusion criteria of cases and controls. Treatment with antibiotics 
within one month prior to the study (systemic or topical therapy) 
or current flares (inflamed lesions, cases). 
Other medications. Seven of the included cases administered 
themselves with topical Resorcinol in the groin. Healthy controls 
were not on any other type of medications at the time of investiga-
tion. We did not obtain specific information on oral contraceptives 
among patients with HS or healthy controls. 
Biopsies and HE staining
Prior to injection of anaesthetics, the skin was cleansed with etha-
nol swabs (FastCare®, 70% Isopropyl Alcohol, Zhejian, China) to 
reduce the number of surface microorganisms.
Axillary skin was anesthetized using a 2% solution of lidocaine 
and adrenaline (no preservatives). A 4-mm punch biopsy was 
obtained in the axilla of patients with HS and healthy controls. 
The biopsy was stored in formalin and subsequently paraffin 
embedded according to the standard operating procedure of the 
pathology department, Roskilde Hospital. In order to identify the 
pilosebaceous units each paraffin block was sectioned at 5+ levels, 
each level consisting of 7 slides (4 µm thick), and processed until 
a representative pilosebaceous unit was identified. The slide in 
the middle group was stained with haematoxylin and eosin (HE) 
and examined by standard light microscopy for the presence of 
representative areas of pilosebaceous units and subsequent iden-
tification of bacteria and grading of inflammation. The pathologist 
who performed the HE investigations was blinded. 
PNA-FISH staining
Paraffin-embedded tissues were deparaffinized using a standar-
dized method (27): (i) xylene (2 × 5 min), (ii) 99% ethanol (2 × 3 
min.), (iii) 96% ethanol (2×3 min.), (iv) Milli-Q water (3 × 3 min), 
incubated in 90 min at 55°C with PNA-FISH-TexasRed (red) 
conjugated (a specific universal bacterial (UniBac) 16S ribosomal 
RNA) probe (AdvanDx, Woburn, MA, USA). Additional staining 
by a specific coagulase-negative staphylococci (CNS) PNA-FISH 
probe was performed on slides categorized as positive by the use 
of the specific Unibac probe. The slides were incubated in wash 
buffer (AdvanDx, Woburn, MA, USA) for 30 min at 55°C and 
subsequently counter-stained with 4’,6-diamidino-2-phenylindole 
(DAPI) (Life Technologies, Oregon, USA) (3 µM) for 15 min at 
RT, rinsed in Milli-Q water, added mounting media (Prolong Gold, 
Life technologies, Oregon, USA) and subsequently mounted on a 
coverslide and sealed with clear nail polish. 
Confocal laser scanning microscopy and slide scanning
Two investigators preformed the CLSM analysis unblinded. The 
PNA-FISH/DAPI stained slides were examined by CLSM (Axio 
Imager.Z2, LSM710 CLSM; Zeiss, Oberkochen, Germany) and 
the accompanying 3D reconstruction software (Zen 2010, version 
6.0; Zeiss, Oberkochen, Germany). Fluorescence images were 
recorded at 405, 488 and 594 nm excitation wavelength and an 
emission wavelength at 410–483 nm (blue), 492–589 nm (green) 
and 599–690 nm (red), respectively. The lasers were used in com-
bination with the corresponding beam-splitters MBS 488/594 and 
MBs_InVin 405 (Zeiss, Oberkochen, Germany). The objectives 
used were 40×/1.3 (numerical aperture) Plan-Neoflour and 63×/1.4 
plan-apochromat oil objectives (Zeiss, Oberkochen, Germany). As 
the remaining non-stained tissue appeared weak green by autofluo-
rescence, the images were taken in 1 track and thus intensified the 
green signal by the use of all 3 lasers. The images had a resolution 
of 1,024×1,024 pixels and a colour depth of 16 bits. Each pixel 
was scanned twice and subsequently deconvoluted into Tiff-files 
(Imaris 8 ×64 version 8.1.2, Bitplane, Zürich, Switzerland).
In addition to standard light microscopy, CLSM were perfor-
med on a minimum of 3 slides; 1 or 2 on each side of the HE 
slide. With regard to the classification of positive vs. negative 
samples, a definition of bacterial aggregates was applied. In a 
recently published study, bacterial aggregates exceeding 5 µm in 
diameter were categorized as biofilm (28). The given classifica-
tion for quantitative assessment of the bacterial aggregates was 
subsequently defined by the following: 0 = no bacteria detected or 
single scattered cells < 10, 1 = 5–10 µm aggregates or single scat-
tered cells > 10, 2 = 10–50 µm aggregates, 3 > 50 µm aggregates. 
For each of the positive samples, the bacterial morphology and 
the location of the findings was noted. The entire PNA-FISH slide 
was reviewed. Overall, the PNA-FISH CLSM results reflect that 
specific slide from each participant that yielded the highest positive 
score in aggregate size.
Due to staining with the PNA-FISH probe and DAPI, active 
bacteria were visualized as bright-red or pink in a combined mi-
croscope filter, whereas more dormant bacteria appeared purple 
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In addition, the fluorescence-stained slides were scanned using 
a digital slide scanner (Axio scan. Z.1, Zeiss, Oberkochen, Ger-
many) with a 20×/0.95 objective (Zeiss, Oberkochen, Germany) 
providing an optimized overview of the slides.
Statistical analysis
The frequent distribution of bacterial aggregate quantification 
between the 2 groups of participants was analysed by Fischer’s 
exact test. In addition, a χ2 test was performed on the location of 
bacterial aggregates. The criteria for statistical significance was 
p < 0.05. The analyses were performed in GraphPad Prism 5.02 
software (GraphPad Software Inc., California, USA).
RESULTS
Our study comprised 24 HS cases and 24 healthy con-
trols. The background factors and characteristics of the 
HS group and controls showed that a majority of the 
patients with HS were predominately younger, female 
and smokers (Table I). For each participant 4 histological 
slides (3 CLSM samples (Universal PNA-FISH) and 1 
HE sample) were examined. With additional CNS PNA-
FISH staining of Universal PNA-FISH-positive samples 
(n = 25 positive), the overall investigation yielded, in 
total, investigations of 217 slides. 
Overall, PNA-FISH and CLSM examinations of pre-
clinical HS skin showed an absence of bacterial aggre-
gates at the stratum corneum (SC) and in hair follicles 
compared with healthy controls. As shown in Table II, 
only 12% of the HS samples were categorized as positive 
for small aggregates or single scattered cells. The 12% 
of the HS patients who had bacterial aggregates were 2 
females and one male. At the time of investigation, none 
of the 3 patients was on any medications. Thus, the ma-
jority of the HS samples showed no bacterial aggregates 
(Figs 1 and 2). In comparison, PNA-FISH and CLSM 
examinations demonstrated morphologically significant 
presence of bacterial aggregates (biofilm formations) 
in 92% of the healthy controls. The majority of the ag-
gregates were found in hair follicles (64%) or in the SC 
(36%) (Table II and Figs 3 and 4).  
The morphology of the bacterial aggregates were 
predominantly classified as cocci (92%) whereas rods 
constituted only a minor percentage (8%) 
(Table II). Of the 92% categorized as 
positive by the use of the Universal PNA-
FISH probe, only 35% of the samples were 
positive for CNS bacteria (Table II). 
Quantification of the bacterial aggregates 
showed mainly measures of 10–50 µm 
(diameter) (Table II and Fig. 4). In gene-
ral, there was a tendency for more active 
bacterial cells to be present in SC, while 
bacteria present in the hair follicles were 
a mixture of either active and dormant or 
pure dormant cells (29).
Statistical analysis on the qualitative 
validation of bacterial aggregates yielded 
a significantly decreased occurrence in 
HS cases compared with healthy controls 
(p < 0.0001). In addition, a significant dif-
Table I. Background factors and characteristics
Characteristic HS patients Healthy controls
Total subjects analysed, n 24 24
Age, years, mean (range) 39 (19–59) 32 (18–52)
Female:male, % 80:20 50:50
Smoking status, % 65 n.a
Ethnicity: Caucasian, % 100 96
HS Severity (Hurley stage) 1, % 75 n.a.
HS Severity (Hurley stage) 2, % 25 n.a.
HS Severity (Hurley stage) 3, % 0 n.a.
Clinical characteristics of the hidradenitis suppurativa (HS) group and the healthy 
control group. Smoking was self-reported. HS severity according to Hurley stages 
(1 = mild, 2 = moderate, 3 = severe).
Table II. Bacterial quantification, distribution, morphology and 







Negative, no bacteria detected
  < 5 µm or SSC <10 cells (0) 88 8
Positive aggregate sizes
  5–10 µm or SSC >10 (1) 4 25
  10–50 µm (2) 8 50
  >50 µm (3) 0 17
Distribution of aggregates in positive samples
  Stratum corneum 0 36
  HF; infundibulum 33 46
  HF; isthmus, suprabulbar, bulb 66 18
Morphology and species in positive samples
  Cocci 100 92
  Rods 0 8
  CNS-positive 0 35
Histopathology
  Low-grade inflammation 50 16
Bacterial findings and histopathology by the use of confocal laser scanning 
microscopy/peptide nucleic acid fluorescent in situ hybridization and light microscope/
hematoxylin eosin, respectively. Quantification of bacterial findings: 0 = negative 
or side scatter < 10 cells, 1 = 5–10 µm aggregates or single scattered cells (SSC) 
> 10 cells, 2 = 10–50 µm aggregates, 3 > 50 µm aggregates. For the positive 
samples, the bacterial morphology and the location of the findings was noted. 
The location of bacterial aggregates in the hair follicle (HF) was categorized as 
either infundibulum or HF (involving the isthmus, suprabulbar or bulb). Negative: 
no bacteria detected; CNS: coagulase-negative staphylococci.
Fig. 1. Distribution and quantification 
of bacterial aggregates in pre-
clinical hidradenitis suppurativa 
(HS) patients vs. healthy controls. 
(a) In healthy controls, bacterial 
aggregates were found in the majority 
of the samples, primarily situated in 
the hair follicle (HF) or at the stratum 
corneum (SC). In the pre-clinical HS 
a high occurrence of negative samples 
were found. Only 3 samples were found 
positive for small bacterial aggregates. 
(b) Quantification of bacterial aggregates 
in skin biopsies shown in a dot plot with 
median of 0 (zero) and of 2 for the HS 
patients and controls, respectively. Each 
dot represents the quantification of one 
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ference was found in the distribution of aggregates in 
relation to location (p < 0.0001).
Histopathological investigations of the biopsies of 
HS cases and controls were in agreement with the 
CLSM findings, showing good morphological correla-
tion between biofilm aggregates found in HE slides and 
the corresponding CLSM images (Fig. 4). According to 
clinical routine practice, depending on the presence of 
lymphocytes, the inflammation was graded on a scale 
ranging from 0 to 3 (none, mild, moderate or severe).
Although all biopsies were obtained 
from clinically unaffected skin, a signi-
ficant proportion of HS samples (50%) 
showed signs of low-grade inflammation 
(mild presence of lymphocytes). In com-
parison, only 16% in the control group 
presented low-grade inflammation. A 
detailed examination of the inflammation 
among the HS cases revealed widely scat-
tered lymphocytic infiltrates, mast cells, 
dilated hair follicles and keratin plug-
ging of the infundibulum. Occasionally, 
plasma-cells, neutrophils and eosinophils 
granulocytes were seen in both groups. 
DISCUSSION 
Our study demonstrated significant diffe-
rences in the distribution and quantity of 
the cutaneous microbiota as well as bio-
film formations in clinically non-affected 
axillary skin of patients with HS compared with healthy 
controls (Fig. 4), with fewer bacteria and less biofilm 
found in HS. The observations are in sharp contrast 
with our initial hypothesis of an increased presence of 
biofilm in clinically unaffected HS skin. Nevertheless, 
these results may give rise to new pathogenic concepts 
for HS. The homogeneity observed in the 2 groups is 
statistically significant, and it is therefore suggested that 
the results may be extrapolated to HS populations and 
healthy individuals on a larger scale. 
PNA-FISH and CLSM are often used as the gold 
standard when spatial insights on the distribution of bac-
terial aggregates are required (27, 28, 30–32). Although, 
PNA-FISH and CLSM does not depict the extracellular 
matrix of the bacterial aggregates, the applicability of the 
technique has been demonstrated in various skin diseases 
(25, 31, 33–35). Previous studies have suggested a pos-
sible pathogenic role for biofilm in the development of 
HS (25, 26). A histological retrospective study of biopsies 
from lesional skin in 27 patients with HS was performed 
using CLSM and FISH (25). Biofilm formations were 
seen in one-fifth (20%) of the samples and were primarily 
situated in hair follicles and sinus tracts. However, taking 
our recent findings into account the presence of biofilm 
found in lesional HS skin may thus primarily reflect se-
condary colonization of biofilm-producing bacteria, most 
likely due to rupture of the innate skin barrier. This also 
appears to be in agreement with the bacterial findings 
from lesional HS skin, often revealing a wide spectrum 
of commensal bacteria (biofilm producing), such as CNS 
bacteria (8). This study also verified the presence of CNS 
in the axilla of healthy controls (35%) (Table II). 
Apart from the findings in the HS group, our study also 
importantly demonstrated the normal spatial distribution 
as well as quantification of bacterial aggregates in healthy 
Fig. 2. Slide scan and confocal laser scanning microscopy images of negative 
hidradenitis suppurativa case. (a) Slide scan of hair follicle (HF) (200× magnification). The 
tissue appears green due to auto-fluorescence, while the human nuclei are stained blue by 
4’,6-diamidino-2-phenylindole (DAPI). A strand of hair is visible in the inferior segment of the 
HF (white arrow). Keratinous material appears within the lumen of the HF. (b) Magnification of 
the same HF showing the infundibulum and the isthmus. No bacteria are detected (they would 
have appeared pink/blue). Erythrocytes appear yellow (auto-fluorescence) at the infundibulum 
(white arrows). All slides were stained with DAPI (blue) and peptide nucleic acid – fluorescence 
in situ hybridization UniBac with TexasRed (red).
Fig. 3. Confocal laser scanning microscopy (CLSM) images of control 
sample. (a) Stratum corneum with several bacterial aggregates (biofilm, 
pink colour) marked by white arrows. In (b) and, (c) magnification of the 
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axillary skin using CLSM and PNA-FISH. To the best 
of the author’s knowledge, the healthy microbiota in ax-
illary skin has not previously been visualized by the use 
of CLSM and may therefore be used in other microbiome 
studies for comparison. 
Considering the fact that the intertriginous regions of 
the human skin and, in particular, the axilla, offers highly 
favourable conditions for bacteria to proliferate (36), our 
observation of a reduced presence of bacterial aggrega-
tes in axillary HS skin appears even more interesting. 
Remarkably, alterations in the composition of the skin 
microbiota (dysbiosis) has been shown in the context of 
other skin inflammatory disorders, such as acne vulgaris, 
psoriasis and atopic dermatitis (37). Thus, it may be spe-
culated whether an altered shift in the resident microbiota 
may be implicated in the patho genesis of HS. 
Although bacteria are often referred to as catalysers 
of inflammation, recent studies have demonstrated that 
symbiotic factors produced by the cutaneous and intesti-
nal commensal microbiota beneficially modulate the 
host immune systems, i.e. by regulating inflammatory 
responses (38–43). Thus, substantial evidence supports 
the hypothesis that the normal skin microbiome acts as 
an antimicrobial shield and contributes to normal defence 
at the epidermal interface. It may therefore be specula-
ted whether the altered microbiota (lack of biofilms) in 
pre-clinical HS leave the patients more susceptible to 
invading pathogens. Alternatively, the local dysbiosis 
may trigger immune-mediated inflammation. 
The major advantages of our study are the design (case-
control study) and the extensive investigation of the skin 
samples. Furthermore, there is minimal misclassification 
bias, as an experienced dermatologist diagnosed the 
HS cases. Although, routine ethanol swabs were app-
lied prior to sampling (biopsy) of the skin, remarkable 
biofilm formations (containing both active and dormant 
cells) were seen at the SC (Fig. 3), primarily consisting 
of cocci (92%). Furthermore, the healthy control group 
also exhibited massive biofilm formations within the hair 
follicles (Fig. 4).
Some limitations may have influenced the results. 
Although deodorants and other antiperspirants may 
influence species diversity (44), we did not obtain 
information on personal hygiene or intervals between 
showering and sample collection. Furthermore, the HE 
and PNA-FISH findings were not validated with culture 
data. The HS participants were not sex-matched with 
the healthy controls and potential HS subtypes were not 
stated. The information on use of antibiotics was self-
reported, yielding possible recall bias. Moreover, we 
sampled only once and did not check the development 
of biofilm over time. We have chosen a minimum of 
one month after the last antibiotic treatment as a cut-
off, which is in agreement with a previously published 
guideline on optimized sampling methods in HS (7). In 
addition, we did not visualize the extracellular matrix of 
the bacterial aggregates. 
We detected fewer bacteria and less biofilm, indicating 
a relative lack of skin microbiota in clinically unaffected 
axillary HS skin. The reduced microbiota in patients 
with HS may play an important role in the early course 
of the disease. Moreover, the high level of presence of 
cocci-biofilm (92%) seen among the healthy controls 
highlights the potential biological importance of cocci 
species. Future follow-up studies may determine the 
development of the microbiota over time. Furthermore, 
general investigations of the complex cross-talk between 
the resident microbiota and epithelial cytokines in the 
skin are needed to clarify the mechanisms that modulate 
skin immune homeostasis and subsequent inflammation.
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